Doceree, the network of physician-only platforms for programmatic messaging, has announced a $35 million Series B round led by Creaegis, a digital and technology investment firm. Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the round.
Number1411 Shutterstock
749432248
Double exposure of city, graph, rows of coins and blank space for finance and business concept
Driven solely by the mission to transform healthcare professional (HCP) marketing globally, the funds will enable Doceree to accelerate product development, augment technologies, scale expansion, and expand team.
Founded in 2019, Doceree empowers pharmaceutical and life-sciences companies and healthcare media agencies with solutions that reach HCPs on their networks and within their digital workflows, to achieve better patient health outcomes. The company, with its largest global network of HCP-only digital platforms, has made rapid strides in HCP communications through its programmatic messaging capabilities.
“We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US, but also elsewhere in the same vein. We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space,” said Harshit Jain MD, founder & global CEO, Doceree. Jain further added, “We are growing massively and have competitive edge. We are thrilled about the future as we continue to expand and touch new horizons in the space.”
Doceree has grown more than 100% in the last year with monthly revenue rising five folds between the Series A funding in April 2022 and now. The company has introduced category-first innovations on the demand and supply sides, including Doceree Enterprise, an HCP-focussed global Demand Side Platform (DSP), and Doceree Provider that empowers HCPs to improve health outcomes of their patients. Its HCP marketing ecosystem consists of custom-built solutions that equip life science marketers to engage with physicians at opportune moments with contextual messaging and evaluate campaign performances to improve script lift.
On the back of the response to its solutions in the US, India and the European markets, Doceree expanded its footprints to Africa, Southeast Asia (SEA), and the Gulf Cooperation Council (GCC), curating and iterating solutions that serve the specific needs of marketers in these regions.
“Doceree’s technology platform allows biopharmaceutical companies to connect with physicians like never before. The company’s impressive growth trajectory is an outcome of its unique, data-driven approach to enable communication with precision and relevance. It has been exciting to partner with Harshit and the team since their Series A round, and we are thrilled to continue supporting their pioneering work.” Ashish Venkataramani, partner, Eight Roads Ventures.
A line-up of smart and connected solutions from Doceree’s product portfolio are awaiting launch in the months to come that will bring massive transformational change to the entire ecosystem globally. The products will facilitate HCP targeting like never before, enriching communications at multiple HCP touchpoints in the professional and clinical journeys of physicians.